A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease.

Couderc T, Chrétien F, Schilte C, Disson O, Brigitte M, Guivel-Benhassine F, Touret Y, Barau G, Cayet N, Schuffenecker I, Desprès P, Arenzana-Seisdedos F, Michault A, Albert ML, Lecuit M. · 2008

Read A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. by Couderc T, Chrétien F, Schilte C, Disson O, Brigitte M, Guivel-Benhassine F, Touret Y, Barau G, Cayet N, Schuffenecker I, Desprès P, Arenzana-Seisdedos F, Michault A, Albert ML, Lecuit M. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2242832.txt.

Introduction

Couderc and a large team built a mouse model in 2008 for chikungunya, a mosquito-borne virus causing fever, rash and joint pain. Severe cases involving the brain had appeared in newborns and vulnerable adults, but the basis of severity was unknown. Adult normal mice resisted infection. Newborn mice proved susceptible, with severity depending on age. Mice with partly or fully disabled type-I interferon signalling, a first-line antiviral system, developed mild or severe disease respectively.

In mild infection the virus first multiplied in the liver, then targeted muscle, joint and skin fibroblasts, matching human biopsy findings. In severe infection it also reached the brain, specifically the choroid plexuses and meninges, the brain's fluid and lining tissues. Symptoms thus match the tissues the virus attacks. Youth and weak interferon signalling are identified as risk factors.

Catalog record

CREATORCouderc T, Chrétien F, Schilte C, Disson O, Brigitte M, Guivel-Benhassine F, Touret Y, Barau G, Cayet N, Schuffenecker I, Desprès P, Arenzana-Seisdedos F, Michault A, Albert ML, Lecuit M.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2242832

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

A Mouse Model for Chikungunya: Young Age and Inefficient Type-I Interferon Signaling Are Risk Factors for Severe Disease By Thérèse Couderc, Fabrice Chrétien, Clémentine Schilte, Olivier Disson, Madly Brigitte, Florence Guivel-Benhassine, Yasmina Touret, Georges Barau, Nadège Cayet, Isabelle Schuffenecker, Philippe Desprès, Fernando Arenzana-Seisdedos Published in: PLoS Pathogens DOI: 10.1371/journal.ppat.0040029 ABSTRACT Chikungunya virus (CHIKV) is a re-emerging arbovirus responsible for a massive outbreak currently afflicting the Indian Ocean region and India. Infection from CHIKV typically induces a mild disease in humans, characterized by fever, myalgia, arthralgia, and rash. Cases of severe CHIKV infection involving the central nervous system (CNS) have recently been described in neonates as well as in adults with underlying conditions. The pathophysiology of CHIKV infection and the basis for disease severity are unknown. To address these critical issues, we have developed an animal model of CHIKV infection. We show here that whereas wild type (WT) adult mice are resistant to CHIKV infection, WT mouse neonates are susceptible and neonatal disease severity is age-dependent. Adult mice with a partially (IFN-α/βR+/−) or totally (IFN-α/βR−/−) abrogated type-I IFN pathway develop a mild or severe infection, respectively. In mice with a mild infection, after a burst of viral replication in the liver, CHIKV primarily targets muscle, joint, and skin fibroblasts, a cell and tissue tropism similar to that observed in biopsy samples of CHIKV-infected humans. In case of severe infections, CHIKV also disseminates to other tissues including the CNS, where it specifically targets the choroid plexuses and the leptomeninges. Together, these data indicate that CHIKV-associated symptoms match viral tissue and cell tropisms, and demonstrate that the fibroblast is a predominant target cell of CHIKV. These data also identify the neonatal phase and inefficient type-I IFN signaling as risk factors for severe CHIKV-associated disease. The development of a permissive small animal model will expedite the testing of future vaccines and therapeutic candidates. INTRODUCTION Chikungunya virus (CHIKV) was first isolated in Tanzania in 1953 [1], and has recently emerged in islands of the Indian Ocean in 2005, and engendered the largest Chikungunya fever epidemic on record [2]. The most affected region was the island of La Réunion, where CHIKV infected approximately a third of the island's inhabitants (i.e., ∼300,000) [3–5]. The outbreak, which now also involves India with an estimated 1.3 million cases [6–8], has a significant potential to spread globally given the wide distribution of its arthropod vector [9,10]. CHIKV is a member of the genus Alphavirus in the family of Togaviridae. Alphaviruses are small, enveloped viruses with a message-sense RNA genome that encodes four non-structural proteins (nsP1–4) and three structural proteins (C, E1–2). This arbovirus is maintained in nature by uninterrupted cycles of transmission between mosquitoes and vertebrate hosts such as macaques [11–13]. Several alphaviruses cause disease in humans, primarily as a result of epizootic infections. These include the American encephalitic alphaviruses and several species in the Semliki Forest Virus group, principally the Afro-Asian CHIKV, the African O'Nyong-Nyong virus, as well as the Australasian Barmah Forest virus and Ross River virus [14]. CHIKV infection is characterized by fever, arthralgia, myalgia, rash and headache. During the La Réunion Island outbreak, previously unreported severe forms of Chikungunya infection were observed in adults, complicated by encephalopathy and hemorrhagic fever. These severe cases almost exclusively occurred in adults with underlying conditions such as diabetes, alcoholic hepatopathy or impaired renal function [3,15]. Moreover, while CHIKV-associated fatalities had not been reported prior to this outbreak, at least 213 persons infected with CHIKV died in La Réunion Island [16,17]. Finally, although never described before, per-partum mother-to-child CHIKV transmission has been observed and is associated with severe neonatal disease characterized in more than half of the cases by encephalopathy [18,19]. The pathophysiology of human CHIKV infection has so far remained essentially unknown, in part because of the lack of a permissive small animal model. In order to gain a better understanding of CHIKV-associated pathophysiology, we have developed a mouse model of infection. Using this model system and comparing it to human samples, we have uncovered the following pathophysiological features of CHIKV infection: (i) viral dissemination and disease severity are strongly increased during the neonatal period, (ii) type-I IFN signalling plays a critical role in the control of the infection and is associated with severe infection when deficient, (iii) symptomatic organs are those infected by CHIKV, and (iv) fibroblasts of connective tissues are prominent cell targets in vivo, in permissive mice as well as in humans. Together, this study offers the first in depth in vivo analysis of CHIKV cellular tropism and offers a validated small animal model that may prove useful for the development and testing of novel vaccine and therapeutic strategies. RESULTS Neonatal Mice Are Permissive to CHIKV Infection In order to study the pathophysiology of CHIKV infection in the adult and neonatal hosts, we aimed to develop a small animal model of infection. We first inoculated a series of classical laboratory mouse strains: outbred OF1 mice and inbred C57BL/6 and 129s/v mice. Intra-dermal (ID) injection of 106 PFU of CHIKV-21, isolated from an individual from La Reunion with central nervous system (CNS) symptoms [4], showed that WT adult OF1 C57BL/6 and 129s/v mice are resistant to CHIKV infection. Neither morbidity nor mortality was observed following infection and no infectious virus could be recovered from tissues (unpublished data). In contrast, neonatal C57BL/6 mice exhibited an age-dependent lethality to CHIKV infection (Figure 1A): six-day-old and 9-day-old mice all developed flaccid paralysis on D6 or D7 post infection (pi), and all 6-day-old mice died before D12 pi, whereas more than half of 9-day-old infected mice recovered. Strikingly, by day 12 of life, C57BL/6 mice showed neither morbidity nor mortality following infection. We investigated the kinetic of virus replication in tissues of 9-day-old mice at D3 and D5 pi and at the onset of symptoms (D7 pi). Infectious virus was detected at low level at D3 pi in serum and at D5 and D7 pi in liver (Figure 1B). Strikingly, at all time points analyzed, infectious CHIKV was detected very abundantly in muscle, joint and skin and to a lower extent in the brain (Figure 1B). [Figure: CHIKV Infection in Mouse Neonates(A) Survival of mouse neonates according to their age. Mouse neonates were inoculated with 106 PFU of CHIKV via the ID route and observed for lethality (n = 6 per group). (B) Viral titers in tissues of 9-day-old neonates. Mice were inoculated with 106 PFU of CHIKV via the ID route and sacrificed at the indicated time points. The amount of infectious virus in serum and tissues were quantified by TCID50. Each data point represents the arithmetic mean ± SD for at least four mice. The broken line indicates the detection threshold.] Together, these results establish that, as observed in humans, CHIKV pathogenicity is strongly age-dependent in mice, and that in less-than 12 day-old mouse neonates, CHIKV induces a severe disease. Of note, in the infected neonatal mice, CHIKV is abundantly detected in the same organs than those symptomatic in humans, particularly infected neonates and babies under the age of one year [18]. IFN-α/βR+/− and IFN-α/βR−/− Animals Provide In Vivo Models for Mild and Severe Forms of CHIKV Infection, Respectively That neonatal mice but not adult mice were permissive to CHIKV

Read the complete text